74 related articles for article (PubMed ID: 6369664)
1. Donor-specific antibodies in renal allograft recipients. A reevaluation of the 51Cr-release assays comparing fibroblast and lymphoid target cells.
Halloran PF; Aprile M; Haddad G; Cunningham K; Robinette MA
Transplantation; 1984 Apr; 37(4):356-8. PubMed ID: 6369664
[TBL] [Abstract][Full Text] [Related]
2. Detection of antidonor antibody: advantages of fibroblast target cells.
Halloran PF; Aprile M; Haddad G; Robinette M
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():49-55. PubMed ID: 386320
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody against fibroblasts in renal transplant recipients: analysis by 51Cr-release assays.
Aprile M; Halloran P; Haddad G; Robinette M
Clin Exp Immunol; 1981 Dec; 46(3):565-74. PubMed ID: 7039893
[TBL] [Abstract][Full Text] [Related]
4. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
Dickmeiss E
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
[TBL] [Abstract][Full Text] [Related]
5. Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients.
Descamps B; Gagnon R; van der Gaag R; Feuillet MN; Crosnier J
J Clin Lab Immunol; 1979 Nov; 2(4):303-9. PubMed ID: 395307
[TBL] [Abstract][Full Text] [Related]
6. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
Hargrave SL; Mayhew E; Hegde S; Niederkorn J
Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
[TBL] [Abstract][Full Text] [Related]
7. Possible association of donor blood group A with higher alloantibody responses after renal transplantation.
Halloran PF; Aprile M; Haddad G; Robinette M
Transplantation; 1983 Mar; 35(3):255-8. PubMed ID: 6340278
[TBL] [Abstract][Full Text] [Related]
8. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
Dickmeiss E
Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222
[TBL] [Abstract][Full Text] [Related]
9. IgM antibodies in renal transplantation.
McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
[TBL] [Abstract][Full Text] [Related]
10. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
11. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
12. Blastogenic suppression and alloantibody activity of sera from renal allograft recipients.
Johnson AH; Rossen RD; Hersh EM; Farrow SS; Butler WT; Suki WN
J Clin Invest; 1974 Jan; 53(1):270-8. PubMed ID: 4271573
[TBL] [Abstract][Full Text] [Related]
13. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
14. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
[TBL] [Abstract][Full Text] [Related]
15. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
16. Anti-donor immune responses in prediction of transplant rejection.
Stiller CR; StC Sinclair NR; Abrahams S; McGirr D; Singh H; Howson WT; Ulan RA
N Engl J Med; 1976 Apr; 294(18):978-82. PubMed ID: 130555
[TBL] [Abstract][Full Text] [Related]
17. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD
Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
[TBL] [Abstract][Full Text] [Related]
18. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
[TBL] [Abstract][Full Text] [Related]
19. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
20. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
